Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Farmers Insurance
Argus Health
Cerilliant
Novartis
Healthtrust
Medtronic
Federal Trade Commission
UBS
Merck

Generated: August 16, 2017

DrugPatentWatch Database Preview

DECADRON Drug Profile

« Back to Dashboard

What is the patent landscape for Decadron, and when can generic versions of Decadron launch?

Decadron is a drug marketed by Merck and is included in eight NDAs.

The generic ingredient in DECADRON is dexamethasone acetate. There are thirty-nine drug master file entries for this compound. Additional details are available on the dexamethasone acetate profile page.

Summary for Tradename: DECADRON

Patents:0
Applicants:1
NDAs:8
Bulk Api Vendors: see list67
Clinical Trials: see list82
Patent Applications: see list3,314
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DECADRON at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merck
DECADRON
dexamethasone
TABLET;ORAL011664-004Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Merck
DECADRON
dexamethasone sodium phosphate
INJECTABLE;INJECTION012071-002Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Merck
DECADRON
dexamethasone
TABLET;ORAL011664-003Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Merck
DECADRON
dexamethasone sodium phosphate
SOLUTION/DROPS;OPHTHALMIC, OTIC011984-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Merck
DECADRON
dexamethasone sodium phosphate
INJECTABLE;INJECTION012071-004Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Julphar
Fuji
Cipla
US Department of Justice
Novartis
Citi
McKinsey
Healthtrust
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot